We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCEM:NYSEARCAKuwait Portland Cement Co. KSC Analysis

Data as of 2026-04-23 - not real-time

$11.93

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The PCEM ETF is trading at $11.93, comfortably above its 20‑day ($12.34) and 50‑day ($12.22) SMAs, indicating a short‑term bullish bias. RSI sits near 45, suggesting neither overbought nor oversold conditions, while the MACD histogram remains negative, hinting at lingering downside momentum. Volume is on an upward trend, supporting the price advance toward the $12.94 resistance. The fund’s beta of ~0.9 points to slightly lower volatility than the market, yet 30‑day price swings hover around 29%, reflecting the inherent risk of emerging‑market exposure. With a trailing PE of 24.3 and a modest dividend yield of 0.35%, valuation appears fair but not cheap, and the dividend may not be sustainable given the fund’s growth focus.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages
  • Negative MACD histogram
  • Support level at $11.5

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Increasing volume trend
  • Favorable market sentiment (Extreme Greed)
  • Emerging‑market growth exposure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑run growth potential of non‑China emerging markets
  • Active management seeking upside
  • Diversified country exposure despite non‑diversified structure

Key Metrics & Analysis

Financial Health

P/E Ratio24.3

Technical Analysis

TrendBullish
RSI44.8
Support$11.50
Resistance$12.94
MA 20$12.34
MA 50$12.22
MA 200$11.24
MACDBearish
VolumeIncreasing
Fear & Greed Index86.95

Valuation

GradeFair
TypeGrowth
Dividend Yield0.35%

Risk Assessment

Beta0.90
Volatility28.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.